Red Blood Cell Transfusion
JAMA · 21.11.2023 · 330 (19) · 1892
DOI: 10.1001/jama.2023.12914 ↗Kurz gefasst
Leitlinie in der Zeitschrift JAMA, erschienen am 21.11.2023. Verfasst von Jeffrey L Carson und 26 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey. Hauptthemen laut MEDLINE: Erythrocyte Transfusion, Hemoglobins. Die Arbeit wurde bisher 486-mal zitiert (Crossref) und nennt 83 Literaturangaben.
Abstract (Originalsprache)
Importance Red blood cell transfusion is a common medical intervention with benefits and harms.
Objective
To provide recommendations for use of red blood cell transfusion in adults and children. Evidence Review Standards for trustworthy guidelines were followed, including using Grading of Recommendations Assessment, Development and Evaluation methods, managing conflicts of interest, and making values and preferences explicit. Evidence from systematic reviews of randomized controlled trials was reviewed.
Findings
For adults, 45 randomized controlled trials with 20 599 participants compared restrictive hemoglobin-based transfusion thresholds, typically 7 to 8 g/dL, with liberal transfusion thresholds of 9 to 10 g/dL. For pediatric patients, 7 randomized controlled trials with 2730 participants compared a variety of restrictive and liberal transfusion thresholds. For most patient populations, results provided moderate quality evidence that restrictive transfusion thresholds did not adversely affect patient-important outcomes. Recommendation 1: for hospitalized adult patients who are hemodynamically stable, the international panel recommends a restrictive transfusion strategy considering transfusion when the hemoglobin concentration is less than 7 g/dL (strong recommendation, moderate certainty evidence). In accordance with the restrictive strategy threshold used in most trials, clinicians may choose a threshold of 7.5 g/dL for patients undergoing cardiac surgery and 8 g/dL for those undergoing orthopedic surgery or those with preexisting cardiovascular disease. Recommendation 2: for hospitalized adult patients with hematologic and oncologic disorders, the panel suggests a restrictive transfusion strategy considering transfusion when the hemoglobin concentration is less than 7 g/dL (conditional recommendations, low certainty evidence). Recommendation 3: for critically ill children and those at risk of critical illness who are hemodynamically stable and without a hemoglobinopathy, cyanotic cardiac condition, or severe hypoxemia, the international panel recommends a restrictive transfusion strategy considering transfusion when the hemoglobin concentration is less than 7 g/dL (strong recommendation, moderate certainty evidence). Recommendation 4: for hemodynamically stable children with congenital heart disease, the international panel suggests a transfusion threshold that is based on the cardiac abnormality and stage of surgical repair: 7 g/dL (biventricular repair), 9 g/dL (single-ventricle palliation), or 7 to 9 g/dL (uncorrected congenital heart disease) (conditional recommendation, low certainty evidence). Conclusions and Relevance It is good practice to consider overall clinical context and alternative therapies to transfusion when making transfusion decisions about an individual patient.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey.
- Department of Haematology, Oxford University Hospitals NHS Trust, Oxford, United Kingdom.
- NHSBT, Oxford, United Kingdom.
- Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom.
- Department of Transfusion Medicine, NHS Blood and Transplant, Oxford, United Kingdom.
- Departments of Clinical Epidemiology and Biostatistics and Medicine, McMaster University, Hamilton, Ontario, Canada.
Zitieren
APA
Carson, J. L., Stanworth, S. J., Guyatt, G., Valentine, S., Dennis, J., Bakhtary, S., Cohn, C. S., Dubon, A., Grossman, B. J., Gupta, G. K., Hess, A. S., Jacobson, J. L., Kaplan, L. J., Lin, Y., Metcalf, R. A., Murphy, C. H., Pavenski, K., Prochaska, M. T., Raval, J. S., …, & Pagano, M. B. (2023). Red Blood Cell Transfusion. JAMA, 330(19), 1892. https://doi.org/10.1001/jama.2023.12914
Vancouver
Carson JL, Stanworth SJ, Guyatt G, Valentine S, Dennis J, Bakhtary S, et al. Red Blood Cell Transfusion. JAMA. 2023;330(19):1892. doi:10.1001/jama.2023.12914
BibTeX
@article{Carson2023,
author = {Carson, Jeffrey L and Stanworth, Simon J and Guyatt, Gordon and Valentine, Stacey and Dennis, Jane and Bakhtary, Sara and Cohn, Claudia S and Dubon, Allan and Grossman, Brenda J and Gupta, Gaurav K and Hess, Aaron S and Jacobson, Jessica L and Kaplan, Lewis J and Lin, Yulia and Metcalf, Ryan A and Murphy, Colin H and Pavenski, Katerina and Prochaska, Micah T and Raval, Jay S and Salazar, Eric and Saifee, Nabiha H and Tobian, Aaron A R and So-Osman, Cynthia and Waters, Jonathan and Wood, Erica M and Zantek, Nicole D and Pagano, Monica B},
title = {Red Blood Cell Transfusion},
journal = {JAMA},
year = {2023},
volume = {330},
number = {19},
pages = {1892},
doi = {10.1001/jama.2023.12914}
}
EUVIMED